MBX Biosciences (MBX) Other Operating Expenses (2024 - 2025)

MBX Biosciences has disclosed Other Operating Expenses across 2 years of filings, most recently posting -$21.6 million for Q3 2025.

• Other Operating Expenses for Q3 2025 came in at -$21.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$41.7 million (up 28.72% YoY), and the FY2024 annual result was -$63.7 million, changed N/A from the prior year.
• Other Operating Expenses came in at -$21.6 million for Q3 2025 at MBX Biosciences, down from -$20.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$12.0 million in Q1 2024 to a low of -$25.1 million in Q1 2025.